English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe famous cancer gene p53, which was thought to be less relevant in kidney cancer, may play a larger role than previously appreciated, suggesting new potential for treatment.
Tag: Kidney Cancer
VUMC’s Rathmell to Receive 2019 Eugene P. Schonfeld Award
The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its most prestigious honor, the Eugene P. Schonfeld Award.
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer
Investigational drug with immunotherapy may provide new therapeutic opportunity for patients previously treated for kidney and lung cancer. Pegilodecakin with pembrolizumab and nivolumab shown to be safe in Phase IB study
Urologic Cancer Expert Brings Latest Science to NYU Langone Hospital–Brooklyn
Mohit Gupta, MD, has been appointed director of urologic oncology and brings the latest surgical techniques in the treatment of prostate and urinary cancers to NYU Langone Hospital–Brooklyn.
Urologic Cancer Expert Brings Latest Science to NYU Langone Hospital–Brooklyn
Mohit Gupta, MD, has been appointed director of urologic oncology and brings the latest surgical techniques in the treatment of prostate and urinary cancers to NYU Langone Hospital–Brooklyn.
Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies
Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients PHILADELPHIA—Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, according to…